Morning Overview on MSN
New study flags powerful drug target that could transform glaucoma treatment
Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...
A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic ...
Researchers have identified a metabolically sensitive cell subtype in the eye's drainage system which shows early signs of ...
Single-cell transcriptomics identifies three discrete mouse trabecular meshwork subtypes and demonstrates that an Lmx1b glaucoma mutation drives mitochondrial dysfunction and elevated intraocular ...
The Department of Justice said five ophthalmology practices across Florida paid to end complaints about ultrasound bills to ...
Retinal vein occlusion (RVO) is a severe disease that occurs when a vein in the light-sensitive layer at the back of the eye ...
To yield the benefits of interventional glaucoma treatment, ophthalmologists need a roadmap for how to implement it, according to a speaker here. At the Hawaiian Eye 2026 meeting, Christine Funke, MD, ...
A trial shows minimally invasive nasal trabeculostomy can offer sustained IOP reduction and medication-free success in glaucoma.
Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative ...
Fourth quarter 2025 total revenue is expected to be in the range of $20.3 million to $20.4 million, an increase of 7% at the estimated midpoint compared to the prior year period.
As Glaucoma Awareness Month highlights evolving practice, specialists describe how artificial intelligence, sustained drug ...
Acanthamoeba keratitis is a rare but blinding parasitic eye disease. Experts share how to avoid it and treat it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results